An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study)

Colaboración

Año: 2025

Gallego, A; Madariaga, A; Estévez-García, P; Alberti, F; Carbó, A; Palacio, I; Churruca, C; Gálvez, F; Ortega, ME; Murata, P; Manzano, A; Masvidal, M; Martín-Lorente, C; Hernando, B; Lozano, I; Cueva, JF; García-Illescas, D; Gost, E; Mendiola, M; Redondo, A

Título: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

• D1